STE Stock Overview
Provides infection prevention products and services worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
STERIS plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$214.34 |
| 52 Week High | US$248.24 |
| 52 Week Low | US$195.47 |
| Beta | 0.85 |
| 11 Month Change | -3.08% |
| 3 Month Change | -9.18% |
| 1 Year Change | 5.49% |
| 33 Year Change | -5.71% |
| 5 Year Change | 41.82% |
| Change since IPO | 10,292.24% |
Recent News & Updates
Recent updates
Steris Q2: Anticipating HSD Growth In AST, Upgrade To 'Buy'
Nov 18What Does STERIS plc's (NYSE:STE) Share Price Indicate?
Oct 19
Is STERIS (NYSE:STE) A Risky Investment?
Oct 01Steris: Dental Divestiture, Surgical Instrumentation Acquisition, But Overvalued
Sep 16Earnings Tell The Story For STERIS plc (NYSE:STE)
Sep 13Steris: Q2 Numbers Solidify Buy Thesis
Aug 13STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 59% Above Its Share Price
Aug 08When Should You Buy STERIS plc (NYSE:STE)?
Jul 04Is STERIS (NYSE:STE) Using Too Much Debt?
Jun 13Steris: Moving On, Losing Its Teeth
Apr 14STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price
Mar 29STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet
Mar 07Steris: Strong Healthcare Products Growth Coupled With Weak AST Business
Feb 17STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't
Feb 15An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued
Dec 17Should You Investigate STERIS plc (NYSE:STE) At US$203?
Nov 24Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes
Nov 08We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt
Nov 06Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?
Sep 18Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage
Sep 01When Should You Buy STERIS plc (NYSE:STE)?
Aug 10Steris: Continuing To Grow The Product Lineup
Jun 20Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered
Feb 09Steris declares $0.47 dividend
Feb 01These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well
Feb 01Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)
Dec 28Steris declares $0.47 dividend
Nov 02STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly
Nov 01Steris: Non-GAAP Valuations Supportive Of Substantial Upside
Sep 04STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47
Aug 18STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47
Aug 04Shareholder Returns
| STE | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -2.6% | 1.5% | 2.2% |
| 1Y | 5.5% | 20.9% | 31.7% |
Return vs Industry: STE underperformed the US Medical Equipment industry which returned 21.4% over the past year.
Return vs Market: STE underperformed the US Market which returned 31.1% over the past year.
Price Volatility
| STE volatility | |
|---|---|
| STE Average Weekly Movement | 2.8% |
| Medical Equipment Industry Average Movement | 8.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.8% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: STE has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: STE's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1985 | 18,000 | Dan Carestio | www.steris.com |
STERIS plc provides infection prevention products and services worldwide. It operates through three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in surgical tables, lights, and connectivity solutions, as well as equipment management services.
STERIS plc Fundamentals Summary
| STE fundamental statistics | |
|---|---|
| Market cap | US$21.30b |
| Earnings (TTM) | US$591.38m |
| Revenue (TTM) | US$5.33b |
35.8x
P/E Ratio4.0x
P/S RatioIs STE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| STE income statement (TTM) | |
|---|---|
| Revenue | US$5.33b |
| Cost of Revenue | US$3.01b |
| Gross Profit | US$2.31b |
| Other Expenses | US$1.72b |
| Earnings | US$591.38m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.99 |
| Gross Margin | 43.42% |
| Net Profit Margin | 11.10% |
| Debt/Equity Ratio | 33.8% |
How did STE perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield36%
Payout RatioDoes STE pay a reliable dividends?
See STE dividend history and benchmarks| STERIS dividend dates | |
|---|---|
| Ex Dividend Date | Nov 19 2024 |
| Dividend Pay Date | Dec 19 2024 |
| Days until Ex dividend | 4 days |
| Days until Dividend pay date | 26 days |
Does STE pay a reliable dividends?
See STE dividend history and benchmarks